DIGITX MANAGEMENT CO., LLC

Thesis

DigiTx Partners is a venture capital firm established in 2016, focusing exclusively on early-stage digital health and healthtech companies. Founded as a joint venture between Astellas Pharma and MPM Capital, the firm leverages deep industry expertise and venture capital acumen to invest in innovative founders. Their investment thesis centers on data-driven technologies that generate competitive insights and enhance patient outcomes, with a strategic emphasis on personalized medicine platforms, real-time health data analytics, remote patient monitoring systems, and digital therapeutic solutions. They specifically target companies in digital therapeutics, medical AI & diagnostics, remote patient monitoring, and telehealth & digital consultation. DigiTx Partners prioritizes companies that utilize proprietary or public data for actionable insights, aiming to improve patient experiences and drive operational efficiencies within the healthcare ecosystem, serving health plans, employers, health systems, biopharma, and consumers. The firm primarily invests in pre-seed, seed, and Series A rounds, with typical check sizes ranging from $500,000 to $15 million, and a sweet spot of $2 million to $5 million for seed-stage investments. While primarily operating within the United States, DigiTx Partners also engages in selective international expansion, particularly in Canada and Finland, supported by a team presence in San Francisco, Palo Alto, and the UK.

Related lists

• Pre-seed AI investors
• Pre-seed Healthcare investors
• Seed-stage AI investors